Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

Overview of attention for article published in Investigational New Drugs, August 2006

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 9 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Method of treatment using inhibitors of mitosis

Application US-9561214-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.